TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28929999

Group type: EXPERIMENTAL
Intervention: Adaptive cognitive training (12 individual sessions of 60 to 90 minutes, once a week)
Number of subjects: 80
Study: 24983307

Group type: EXPERIMENTAL
Intervention: Everolimus with reduced exposure cyclosporine A
Number of subjects: 148

Group type: COMPARATOR
Intervention: Enteric-coated mycophenolate sodium and standard-exposure cyclosporine A
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 148
Study: 23078120

Group type: EXPERIMENTAL
Intervention: Laboratory-confirmed influenza
Number of subjects: 3273

Group type: EXPERIMENTAL
Intervention: Laboratory-confirmed respiratory viral infection other than influenza
Number of subjects: 3273

Group type: EXPERIMENTAL
Intervention: Entero/rhinovirus
Number of subjects: 3273

Group type: EXPERIMENTAL
Intervention: Age-related incidence of infections
Number of subjects: 3273
Study: 21421506

Group type: EXPERIMENTAL
Intervention: Glucocorticoid treatment (short-term low-dose)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (lamivudine and routine integrated treatment)
Number of subjects: 87
Study: 18060706

Group type: EXPERIMENTAL
Intervention: Intranasal 17beta‐estradiol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (saline serum physiologic)
Number of subjects: 24
Study: 16594908

Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy (niacin or lovastatin plus colestipol)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional lipid-lowering therapy (diet +/- colestipol)
Number of subjects: 51
Study: 12891467

Group type: EXPERIMENTAL
Intervention: Aprotinin (1 million KIU) administered 15 minutes before delivery
Number of subjects: 84

Group type: COMPARATOR
Intervention: No aprotinin
Number of subjects: 84
Study: 10488974

Group type: EXPERIMENTAL
Intervention: Active treatment with 30 mg beta-carotene and 25,000 IU retinyl palmitate
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 15321345

Group type: EXPERIMENTAL
Intervention: TED stockings applied 1 h before spinal anaesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: No TED stockings applied
Number of subjects: 50
Study: 1707218

Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFLX) 100 mg twice daily for 4 to 15 weeks in group A
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (group B) with no OFLX or other antibiotics
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFLX) in group A
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 48
Study: 6182816

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (hyposensitization) with partially purified timothy extract or two timothy major allergens
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified, but implied as no treatment or different treatment)
Number of subjects: 40
Study: 31127302

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MI): each student received a daily healthy meal along with educational actions
Number of subjects: 1442

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MI)
Number of subjects: 1442

Group type: COMPARATOR
Intervention: Educational intervention (EI)
Number of subjects: 1442
Study: 30959189

Group type: EXPERIMENTAL
Intervention: Vitamin D3 20,000 IU per week
Number of subjects: 399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study: 28662406

Group type: EXPERIMENTAL
Intervention: Eribulin in combination with pertuzumab and trastuzumab
Number of subjects: 30
Study: 26302914

Group type: EXPERIMENTAL
Intervention: 600μg/day CrPic supplementation
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 71
Study: 24206407

Group type: EXPERIMENTAL
Intervention: Ardeh 28 g/d (two tablespoons) for six weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (usual breakfast)
Number of subjects: 41
Study: 20508540

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Concentric exercise
Number of subjects: 20
Study: 18636232

Group type: COMPARATOR
Intervention: Intensive insulin therapy (IIT) alone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy combined with metformin (IIT+MET)
Number of subjects: 21
Study: 16556716

Group type: EXPERIMENTAL
Intervention: GH therapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 12907461

Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study: 11008354

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg od, Amoxycillin 750 mg tid, Omeprazole 20 mg (Group A)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg od, Amoxycillin 750 mg tid, Omeprazole 40 mg (Group B)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Overall treatment (both groups)
Number of subjects: 54
Study: 8797481

Group type: EXPERIMENTAL
Intervention: Chronic manganese exposure (mean duration 20.25 years)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (never worked in Mn mines or had short-term Mn employment)
Number of subjects: 59
Study: 2062155

Group type: EXPERIMENTAL
Intervention: Electromyographic feedback with mirror feedback
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mirror feedback alone
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 25
Study: 6836233

Group type: EXPERIMENTAL
Intervention: Triamcinolone hexacetoide (TH)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Methylprednisolone (MP)
Number of subjects: 24
Study: 3960427

Group type: EXPERIMENTAL
Intervention: Intraoperative irrigation with cefamandole nafate
Number of subjects: 208

Group type: COMPARATOR
Intervention: Perioperative intravenous cefamandole
Number of subjects: 208
Study: 29786471

Group type: EXPERIMENTAL
Intervention: EGCG+RES (epigallocatechin‐gallate 282 mg/d, resveratrol 80 mg/d)
Number of subjects: 25

Group type: COMPARATOR
Intervention: PLA (placebo)
Number of subjects: 25
Study: 27174221

Group type: EXPERIMENTAL
Intervention: Integrative medicine rehabilitation (IMR)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Conventional rehabilitation (CR)
Number of subjects: 360
Study: 25380624

Group type: EXPERIMENTAL
Intervention: Visual conditioning stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory conditioning stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gustatory conditioning stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined conditioning stimuli
Number of subjects: 0
Study: 22832151

Group type: EXPERIMENTAL
Intervention: ST peak during primary PCI
Number of subjects: 363
Study: 21077420

Group type: EXPERIMENTAL
Intervention: Enhanced aesthetics dentures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dentures (control)
Number of subjects: 0
Study: 18713919

Group type: EXPERIMENTAL
Intervention: Silicone wire‐reinforced tube
Number of subjects: 63

Group type: COMPARATOR
Intervention: Parker tube
Number of subjects: 63

Group type: COMPARATOR
Intervention: PVC tube
Number of subjects: 63

Group type: COMPARATOR
Intervention: Parker tube after manipulation
Number of subjects: 63

Group type: COMPARATOR
Intervention: PVC tube after manipulation
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Silicone wire‐reinforced tube vs Parker tube after manipulation
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Silicone wire‐reinforced tube vs PVC tube
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Parker tube vs PVC tube
Number of subjects: 63
Study: 15933276

Group type: EXPERIMENTAL
Intervention: Professional long-term care
Number of subjects: 3107

Group type: EXPERIMENTAL
Intervention: Transitions to professional home care or institutional care
Number of subjects: 3107

Group type: COMPARATOR
Intervention: Transitions from professional home care or institutional care to no care or informal care only
Number of subjects: 3107
Study: 12887843

Group type: COMPARATOR
Intervention: Iron syrup (Group A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Iron powder sprinkled over food (Group B)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 200
Study: 10473961

Group type: EXPERIMENTAL
Intervention: Topical retinaldehyde
Number of subjects: 0
Study: 8574720

Group type: EXPERIMENTAL
Intervention: Zaldaride 20 mg four times daily
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Zaldaride 2 x 20 mg as initial loading dose followed by three doses of 20 mg on the first day and four doses of 20 mg on the second day
Number of subjects: 436

Group type: COMPARATOR
Intervention: Loperamide 2 x 2 mg loading dose followed by a flexible dosage of 2 mg after each unformed stool (maximum of 16 mg daily)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Zaldaride without a loading dose
Number of subjects: 436
Study: 1960058

Group type: EXPERIMENTAL
Intervention: Rose coloured tint
Number of subjects: 20

Group type: COMPARATOR
Intervention: Blue tint
Number of subjects: 20
Study: 7084497

Group type: EXPERIMENTAL
Intervention: P vaginal suppositories
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Dehydrogesterone
Number of subjects: 44

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 44
Study: 30811541

Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 774
Study: 30082572

Group type: EXPERIMENTAL
Intervention: ECG-guided tip location technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional chest radiography tip location technique
Number of subjects: 0
Study: 29871066

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with standardized dermatophagoides farinae extracts for 1 year
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (no SLIT)
Number of subjects: 130
Study: 23269476

Group type: EXPERIMENTAL
Intervention: Mobile-bearing surfaces
Number of subjects: 149

Group type: COMPARATOR
Intervention: Fixed bearings
Number of subjects: 149
Study: 21909728

Group type: EXPERIMENTAL
Intervention: Once-weekly resistance training
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Twice-weekly resistance training
Number of subjects: 155

Group type: COMPARATOR
Intervention: Balance and tone classes
Number of subjects: 155
Study: 21229700

Group type: EXPERIMENTAL
Intervention: Pharmacokinetic simulation program (P (+) group)
Number of subjects: 79

Group type: COMPARATOR
Intervention: No pharmacokinetic simulation program (P (−) group)
Number of subjects: 79

Group type: COMPARATOR
Intervention: No pharmacokinetic simulation program (C group)
Number of subjects: 79
Study: 16969657

Group type: EXPERIMENTAL
Intervention: Carisolv system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hand excavation method
Number of subjects: 0
Study: 16174589

Group type: EXPERIMENTAL
Intervention: Guliu capsule (GLC) combined with 89Sr
Number of subjects: 50

Group type: COMPARATOR
Intervention: 89Sr alone
Number of subjects: 50
Study: 11527250

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) at 1,600 microg/day or 800 microg/day + pranlukast (450 mg/day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pranlukast (450 mg/day) with BDP at 800 microg/day (group I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pranlukast (450 mg/day) with BDP at 1,600 microg/day (group II)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pranlukast (450 mg/day) with BDP at 1,600 microg/day + 5 to 20 mg prednisolone (group III)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pranlukast (450 mg/day) with BDP introduced within the first year of onset of asthma
Number of subjects: 80
Study: 9250457

Group type: EXPERIMENTAL
Intervention: Clamped hyperinsulinemic hypoglycemia (60 mU.m‐2.min‐1) at 2.8 mmol/l
Number of subjects: 8

Group type: COMPARATOR
Intervention: Euglycemia at 5.0 mmol/l
Number of subjects: 8
Study: 8421951

Group type: EXPERIMENTAL
Intervention: THAM plus hyperventilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyperventilation alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: THAM
Number of subjects: 0
Study: 3307582

Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (initial dose of 15,000 U, adjusted thereafter)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Intravenous heparin (bolus injection of 5000 U, followed by an infusion of 1250 U/h, adjusted)
Number of subjects: 103
Study: 31483005

Group type: EXPERIMENTAL
Intervention: Knowledge on food crops
Number of subjects: 3414

Group type: EXPERIMENTAL
Intervention: Increased monthly availability of fruits at households
Number of subjects: 3414

Group type: EXPERIMENTAL
Intervention: Greater variety of fruits in commercial establishments
Number of subjects: 3414

Group type: EXPERIMENTAL
Intervention: Quality of vegetables in commercial establishments
Number of subjects: 3414

Group type: EXPERIMENTAL
Intervention: Greater variety of fruits
Number of subjects: 3414
Study: 28395207

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I); 2 in-person sessions (20-40 min) and 2 telephone sessions (15-20 min)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sleep Hygiene (SH); 1 in-person session and 1 telephone session
Number of subjects: 27
Study: 26261259

Group type: EXPERIMENTAL
Intervention: FOLFIRI plus cetuximab (arm A)
Number of subjects: 592

Group type: COMPARATOR
Intervention: FOLFIRI plus bevacizumab (arm B)
Number of subjects: 592
Study: 22906565

Group type: EXPERIMENTAL
Intervention: Purified anthocyanin mixture (320 mg/d)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Delphinidin-3-Ο-β-glucoside (Dp-3g)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Cyanidin-3-Ο-β-glucoside (Cy-3g)
Number of subjects: 150
Study: 21493326

Group type: EXPERIMENTAL
Intervention: Tragal pumping on the experimental ear
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control ear (no tragal pumping)
Number of subjects: 24
Study: 19290531

Group type: EXPERIMENTAL
Intervention: Erythromycin (3 mg/kg per dose 4 times daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no erythromycin)
Number of subjects: 30
Study: 16681761

Group type: EXPERIMENTAL
Intervention: 200 mg/day of indole-3-carbinol (I3C)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg/day of indole-3-carbinol (I3C)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: indole-3-carbinol (I3C)
Number of subjects: 12
Study: 15296681

Group type: EXPERIMENTAL
Intervention: Quick method of scoring the RTCQ
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Refined method of scoring the RTCQ
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Continuous readiness scale of scoring the RTCQ
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: All three methods of scoring the RTCQ
Number of subjects: 165
Study: 11398549

Group type: EXPERIMENTAL
Intervention: Bass appliance
Number of subjects: 42

Group type: COMPARATOR
Intervention: Twin Block (TB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Twin Block + Headgear (TB + Hg)
Number of subjects: 42
Study: 9427988

Group type: EXPERIMENTAL
Intervention: Echothiophate iodide eyedrops once daily for 4 months
Number of subjects: 41

Group type: COMPARATOR
Intervention: Dexamethasone eyedrops for 1 week after surgery
Number of subjects: 41
Study: 8387885

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy (HFX RT) to a total tumor dose of 64.80 Gy (treatment arm 1)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: HFX RT to the same tumor dose with chemotherapy (CT) consisting of 100 mg of carboplatin, days 1 and 2, and 100 mg of etoposide (VP‐16), days 1‐3 (treatment arm 2)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: HFX RT to the same tumor dose with CT consisting of 200 mg of CBCDA, days 1 and 2, and 100 mg of VP‐16, days 1‐5 (treatment arm 3)
Number of subjects: 169
Study: 3687518

Group type: EXPERIMENTAL
Intervention: Interaction of dietary restraint and depression
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Interaction of dietary restraint and biphasic mood shifts
Number of subjects: 73
Study: 31238343

Group type: EXPERIMENTAL
Intervention: Partially Hydrolyzed Formula (PHF)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard Formula (SF)
Number of subjects: 110
Study: 29713086

Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 376

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 376
Study: 27760995

Group type: EXPERIMENTAL
Intervention: L-tryptophan
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: L-leucine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Glucose and water
Number of subjects: 20
Study: 25911631

Group type: EXPERIMENTAL
Intervention: REHLOW (250 g carbohydrates in 400 mL of water)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: REHFULL (same syrup plus water to match fluid losses, 3170 ± 190 mL)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Comparison of REHLOW and REHFULL
Number of subjects: 9
Study: 23294032

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (SCIG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Subcutaneous saline (control)
Number of subjects: 30
Study: 21500927

Group type: EXPERIMENTAL
Intervention: Full attention during training and testing
Number of subjects: 180

Group type: COMPARATOR
Intervention: Concurrent cognitive load during training and testing
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Concurrent cognitive load during training
Number of subjects: 180
Study: 17200103

Group type: EXPERIMENTAL
Intervention: Faith-based weight-loss intervention (treatment group)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study: 16734311

Group type: EXPERIMENTAL
Intervention: Compoglass
Number of subjects: 57

Group type: COMPARATOR
Intervention: FluroShield
Number of subjects: 57
Study: 14630377

Group type: EXPERIMENTAL
Intervention: Stroke information packet
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control packet on colorectal cancer
Number of subjects: 177
Study: 11106204

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg o.d. for 8 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg o.d. after placebo
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo after omeprazole
Number of subjects: 29
Study: 7860820

Group type: EXPERIMENTAL
Intervention: Film and vibration
Number of subjects: 145

Group type: COMPARATOR
Intervention: Vibration
Number of subjects: 145

Group type: COMPARATOR
Intervention: Film
Number of subjects: 145
Study: 2571726

Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normotensive subjects
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patients taking beta-blocker medication
Number of subjects: 60
Study: 1056801

Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy (biweekly methotrexate and monthly prednisone and vincristine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 0
Study: 31482970

Group type: EXPERIMENTAL
Intervention: Tannin extract of Acacia mangium at 1% concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tannin extract of Myristica fragrans at 1% concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tannin extract of Acacia villosa at 1% concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tannin extract of Calliandra calothyrsus at 1% concentration
Number of subjects: 0
Study: 30665606

Group type: EXPERIMENTAL
Intervention: four-session web-based intervention (Partners Connect)
Number of subjects: 234

Group type: COMPARATOR
Intervention: waitlist control group
Number of subjects: 234
Study: 28431010

Group type: EXPERIMENTAL
Intervention: BMS-936559 (0.3 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 26138674

Group type: EXPERIMENTAL
Intervention: DCM applied since 2009 (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DCM newly introduced during the study (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention based on regular and standardized QoL rating (Group C)
Number of subjects: 0
Study: 24418949

Group type: EXPERIMENTAL
Intervention: Electronic interactive SSE educational intervention
Number of subjects: 500

Group type: COMPARATOR
Intervention: Workbook intervention
Number of subjects: 500

Group type: COMPARATOR
Intervention: In-person intervention
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Electronic interactive intervention
Number of subjects: 500
Study: 22938002

Group type: EXPERIMENTAL
Intervention: Extreme day cream (EXD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extreme night treatment (EXN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extreme preparations (EXD and EXN)
Number of subjects: 0
Study: 19574870

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided infraclavicular block
Number of subjects: 232

Group type: COMPARATOR
Intervention: Transarterial axillary block
Number of subjects: 232
Study: 17616840

Group type: EXPERIMENTAL
Intervention: Twice-weekly, group-based, moderate-intensity walking program (n = 77)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Daily vitamin B pills (n = 78)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Light-intensity placebo activity program (n = 75)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo pills (n = 74)
Number of subjects: 155
Study: 14687958

Group type: COMPARATOR
Intervention: Standard drug treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced drug treatment (e.g. case management and added social services)
Number of subjects: 0
Study: 11120398

Group type: EXPERIMENTAL
Intervention: 0.2 microg/kg doses of pentagastrin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 0.4 microg/kg doses of pentagastrin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 0.6 microg/kg doses of pentagastrin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 0.8 microg/kg doses of pentagastrin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 9830263

Group type: EXPERIMENTAL
Intervention: 2% butenafine and 20% urea cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overall assessment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 60